Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Rasche

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Hematology/Oncology Clinics of North America|January 9, 2024
Impact of Clonal Heterogeneity in Multiple MyelomaCarolina Schinke, Leo Rasche, Marc S Raab, et al.
Presse Medicale (Paris, France : 1983)|December 11, 2024
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?Xiang Zhou, K Martin Kortuem, Leo Rasche, et al.
International Journal of Molecular Sciences|March 16, 2019
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple MyelomaLeo Rasche, K Martin Kortüm, Marc S Raab, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 15, 2024
Comprehensive Review of Bispecific Antibody Constructs In Multiple Myeloma: Affinities, Dosing Strategies and Future PerspectivesJohannes M Waldschmidt, Leo Rasche, K Martin Kortüm, et al.
Virchows Archiv : an International Journal of Pathology|December 19, 2019
A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integrationChristian M Schürch, Leo Rasche, Leonie Frauenfeld, et al.
Haematologica|October 20, 2022
BCMA loss in the epoch of novel immunotherapy for multiple myeloma: from biology to clinical practiceXiang Zhou, Leo Rasche, K Martin Kortüm, et al.
Haematologica|July 1, 2021
Novel immunotherapies in multiple myeloma - chances and challengesLeo Rasche, Ralph Wäsch, Markus Munder, et al.
European Journal of Haematology|September 3, 2015
'Real-life' experience of preapproval carfilzomib-based therapy in myeloma - analysis of cardiac toxicity and predisposing factorsSophia Danhof, Martin Schreder, Leo Rasche, et al.
Bone Marrow Transplantation|August 22, 2019
The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCTHermann Einsele, Leo Rasche, Max S Topp, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|April 1, 2008
Laparoscopic insertion with tip suturing, omentectomy, and ovariopexy improves lifespan of peritoneal dialysis catheters in childrenAlp Numanoglu, Leo Rasche, Michael A Roth, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Hematology/Oncology Clinics of North America|January 9, 2024
Impact of Clonal Heterogeneity in Multiple MyelomaCarolina Schinke, Leo Rasche, Marc S Raab, et al.
Presse Medicale (Paris, France : 1983)|December 11, 2024
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?Xiang Zhou, K Martin Kortuem, Leo Rasche, et al.
International Journal of Molecular Sciences|March 16, 2019
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple MyelomaLeo Rasche, K Martin Kortüm, Marc S Raab, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 15, 2024
Comprehensive Review of Bispecific Antibody Constructs In Multiple Myeloma: Affinities, Dosing Strategies and Future PerspectivesJohannes M Waldschmidt, Leo Rasche, K Martin Kortüm, et al.
Virchows Archiv : an International Journal of Pathology|December 19, 2019
A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integrationChristian M Schürch, Leo Rasche, Leonie Frauenfeld, et al.
Haematologica|October 20, 2022
BCMA loss in the epoch of novel immunotherapy for multiple myeloma: from biology to clinical practiceXiang Zhou, Leo Rasche, K Martin Kortüm, et al.
Haematologica|July 1, 2021
Novel immunotherapies in multiple myeloma - chances and challengesLeo Rasche, Ralph Wäsch, Markus Munder, et al.
European Journal of Haematology|September 3, 2015
'Real-life' experience of preapproval carfilzomib-based therapy in myeloma - analysis of cardiac toxicity and predisposing factorsSophia Danhof, Martin Schreder, Leo Rasche, et al.
Bone Marrow Transplantation|August 22, 2019
The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCTHermann Einsele, Leo Rasche, Max S Topp, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|April 1, 2008
Laparoscopic insertion with tip suturing, omentectomy, and ovariopexy improves lifespan of peritoneal dialysis catheters in childrenAlp Numanoglu, Leo Rasche, Michael A Roth, et al.
Pageof 17